Abstract
The purpose of this study was to determine the efficacy of orally administered milbemycin oxime in the treatment of canine scabies. The study includes 56 dogs with a clinical history and presentation compatible with canine sarcoptic mange. Scabies mites or eggs were found on microscopy of skin scrapings from all dogs in the study. The dogs were treated with milbemycin oxime at a dose of 2 mg kg−1weekly for a total of three doses. All dogs were less pruritic or nonpruritic after the third treatment, but 29% of the dogs had increased pruritus and positive skin scrapings 3–6 weeks after the third treatment. The results of this study show less efficacy (71%) than previously reported.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
